The post Bonk Breaks Into Wall Street With First-Ever Nasdaq Listing Through Safety Shot appeared on BitcoinEthereumNews.com. Altcoins In a groundbreaking move for the crypto industry, memecoin Bonk ($BONK) is heading to Nasdaq after securing a major deal with beverage company Safety Shot (Nasdaq: SHOT). The partnership marks the first time a U.S.-listed company will share revenue directly with a memecoin. According to the announcement on August 12, Safety Shot acquired a 10% revenue-sharing stake in Bonk’s launchpad platform, BONK.fun. The deal included $25 million worth of BONK tokens, which served as the main consideration for newly issued convertible preferred shares valued at $35 million. As part of the agreement, Safety Shot will change its ticker symbol to $BNKK, signaling a full rebrand aligned with Bonk’s growing influence in both traditional markets and crypto. Governance Shake-Up and Strategic Alignment The transaction goes beyond finances, introducing Bonk’s founding team into Safety Shot’s leadership. Mitchell Rudy, known in the community as “Nom,” along with other BONK core members, will join the company’s board of directors, securing 50% of board representation. This move gives the memecoin direct influence over corporate decision-making. Market response has been highly volatile, with Safety Shot’s stock swinging sharply following the news. Reports indicate a steep 50% drop followed by a rapid intraday rebound of nearly 37%. Trump-Linked Funding and Revenue Innovation The funding is being facilitated by Dominari, a holding company tied to the Trump family, further elevating the political and financial spotlight around the transaction. This alliance is unprecedented, making Safety Shot the first Nasdaq-listed company to integrate a memecoin into its revenue model. The 10% revenue stake in letsBONK.fun, Bonk’s Solana-based launchpad, ensures that token holders are directly tied to the company’s future performance. Analysts suggest this model could set a precedent for other meme-inspired projects seeking to cross over into regulated markets. A Historic First for Memecoins This deal signifies more than… The post Bonk Breaks Into Wall Street With First-Ever Nasdaq Listing Through Safety Shot appeared on BitcoinEthereumNews.com. Altcoins In a groundbreaking move for the crypto industry, memecoin Bonk ($BONK) is heading to Nasdaq after securing a major deal with beverage company Safety Shot (Nasdaq: SHOT). The partnership marks the first time a U.S.-listed company will share revenue directly with a memecoin. According to the announcement on August 12, Safety Shot acquired a 10% revenue-sharing stake in Bonk’s launchpad platform, BONK.fun. The deal included $25 million worth of BONK tokens, which served as the main consideration for newly issued convertible preferred shares valued at $35 million. As part of the agreement, Safety Shot will change its ticker symbol to $BNKK, signaling a full rebrand aligned with Bonk’s growing influence in both traditional markets and crypto. Governance Shake-Up and Strategic Alignment The transaction goes beyond finances, introducing Bonk’s founding team into Safety Shot’s leadership. Mitchell Rudy, known in the community as “Nom,” along with other BONK core members, will join the company’s board of directors, securing 50% of board representation. This move gives the memecoin direct influence over corporate decision-making. Market response has been highly volatile, with Safety Shot’s stock swinging sharply following the news. Reports indicate a steep 50% drop followed by a rapid intraday rebound of nearly 37%. Trump-Linked Funding and Revenue Innovation The funding is being facilitated by Dominari, a holding company tied to the Trump family, further elevating the political and financial spotlight around the transaction. This alliance is unprecedented, making Safety Shot the first Nasdaq-listed company to integrate a memecoin into its revenue model. The 10% revenue stake in letsBONK.fun, Bonk’s Solana-based launchpad, ensures that token holders are directly tied to the company’s future performance. Analysts suggest this model could set a precedent for other meme-inspired projects seeking to cross over into regulated markets. A Historic First for Memecoins This deal signifies more than…

Bonk Breaks Into Wall Street With First-Ever Nasdaq Listing Through Safety Shot

Altcoins

In a groundbreaking move for the crypto industry, memecoin Bonk ($BONK) is heading to Nasdaq after securing a major deal with beverage company Safety Shot (Nasdaq: SHOT). The partnership marks the first time a U.S.-listed company will share revenue directly with a memecoin.

According to the announcement on August 12, Safety Shot acquired a 10% revenue-sharing stake in Bonk’s launchpad platform, BONK.fun. The deal included $25 million worth of BONK tokens, which served as the main consideration for newly issued convertible preferred shares valued at $35 million.

As part of the agreement, Safety Shot will change its ticker symbol to $BNKK, signaling a full rebrand aligned with Bonk’s growing influence in both traditional markets and crypto.

Governance Shake-Up and Strategic Alignment

The transaction goes beyond finances, introducing Bonk’s founding team into Safety Shot’s leadership. Mitchell Rudy, known in the community as “Nom,” along with other BONK core members, will join the company’s board of directors, securing 50% of board representation. This move gives the memecoin direct influence over corporate decision-making.

Market response has been highly volatile, with Safety Shot’s stock swinging sharply following the news. Reports indicate a steep 50% drop followed by a rapid intraday rebound of nearly 37%.

Trump-Linked Funding and Revenue Innovation

The funding is being facilitated by Dominari, a holding company tied to the Trump family, further elevating the political and financial spotlight around the transaction. This alliance is unprecedented, making Safety Shot the first Nasdaq-listed company to integrate a memecoin into its revenue model.

The 10% revenue stake in letsBONK.fun, Bonk’s Solana-based launchpad, ensures that token holders are directly tied to the company’s future performance. Analysts suggest this model could set a precedent for other meme-inspired projects seeking to cross over into regulated markets.

A Historic First for Memecoins

This deal signifies more than a rebranding — it’s a milestone for crypto legitimacy. By bridging meme culture with Wall Street, Bonk has carved out a path no other memecoin has achieved before. If successful, the experiment could inspire a wave of hybrid corporate-crypto ventures in the coming years.

For now, all eyes are on Nasdaq, where $BNKK will debut as the first stock symbol explicitly tied to a memecoin.


The information provided in this article is for informational purposes only and does not constitute financial, investment, or trading advice. Coindoo.com does not endorse or recommend any specific investment strategy or cryptocurrency. Always conduct your own research and consult with a licensed financial advisor before making any investment decisions.

Author

Alex is an experienced financial journalist and cryptocurrency enthusiast. With over 8 years of experience covering the crypto, blockchain, and fintech industries, he is well-versed in the complex and ever-evolving world of digital assets. His insightful and thought-provoking articles provide readers with a clear picture of the latest developments and trends in the market. His approach allows him to break down complex ideas into accessible and in-depth content. Follow his publications to stay up to date with the most important trends and topics.



Next article

Source: https://coindoo.com/bonk-breaks-into-wall-street-with-first-ever-nasdaq-listing-through-safety-shot/

Market Opportunity
Sport.Fun Logo
Sport.Fun Price(FUN)
$0.08702
$0.08702$0.08702
+335.10%
USD
Sport.Fun (FUN) Live Price Chart
Disclaimer: The articles reposted on this site are sourced from public platforms and are provided for informational purposes only. They do not necessarily reflect the views of MEXC. All rights remain with the original authors. If you believe any content infringes on third-party rights, please contact [email protected] for removal. MEXC makes no guarantees regarding the accuracy, completeness, or timeliness of the content and is not responsible for any actions taken based on the information provided. The content does not constitute financial, legal, or other professional advice, nor should it be considered a recommendation or endorsement by MEXC.

You May Also Like

5 High-Growth Cryptos for 2025: BullZilla Tops the Charts as the Best 100x Crypto Presale

5 High-Growth Cryptos for 2025: BullZilla Tops the Charts as the Best 100x Crypto Presale

BullZilla, World Liberty Financial, MoonBull, La Culex, and Polkadot (DOT) are taking the spotlight among emerging and established crypto projects […] The post 5 High-Growth Cryptos for 2025: BullZilla Tops the Charts as the Best 100x Crypto Presale appeared first on Coindoo.
Share
Coindoo2025/10/18 08:15
Over $145M Evaporates In Brutal Long Squeeze

Over $145M Evaporates In Brutal Long Squeeze

The post Over $145M Evaporates In Brutal Long Squeeze appeared on BitcoinEthereumNews.com. Crypto Futures Liquidations: Over $145M Evaporates In Brutal Long Squeeze
Share
BitcoinEthereumNews2026/01/16 11:35
Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution

Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution

The post Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution appeared on BitcoinEthereumNews.com. In this week’s edition of InnovationRx, we look at possible pain treatments from cannabis, risks of new vaccine restrictions, virtual clinical trials at the Mayo Clinic, GSK’s $30 billion U.S. manufacturing commitment, and more. To get it in your inbox, subscribe here. Despite their addictive nature, opioids continue to be a major treatment for pain due to a lack of effective alternatives. In an effort to boost new drugs, the FDA released new guidelines for non-opioid painkillers last week. But making these drugs hasn’t been easy. Vertex Pharmaceuticals received FDA approval for its non-opioid Journavx in January, then abandoned a next generation drug after a failed clinical trial earlier this summer. Acadia similarly abandoned a promising candidate after a failed trial in 2022. One possible basis for non-opioids might be cannabis. Earlier this year, researchers at Washington University at St. Louis and Stanford published a study showing that a cannabis-derived compound successfully eased pain in mice with minimal side effects. Munich-based pharmaceutical company Vertanical is perhaps the furthest along in this quest. It is developing a cannabinoid-based extract to treat chronic pain it hopes will soon become an approved medicine, first in the European Union and eventually in the United States. The drug, currently called Ver-01, packs enough low levels of cannabinoids (including THC) to relieve pain, but not so much that patients get high. Founder Clemens Fischer, a 50-year-old medical doctor and serial pharmaceutical and supplement entrepreneur, hopes it will become the first cannabis-based painkiller prescribed by physicians and covered by insurance. Fischer founded Vertanical, with his business partner Madlena Hohlefelder, in 2017, and has invested more than $250 million of his own money in it. With a cannabis cultivation site and drug manufacturing plant in Denmark, Vertanical has successfully passed phase III clinical trials in Germany and expects…
Share
BitcoinEthereumNews2025/09/18 05:26